By Y. Peter Kang ( January 22, 2015, 8:43 PM EST) -- A New Jersey federal judge on Thursday granted Mylan Inc. supplemental damages of $13.7 million in the generic-drug maker's feud with GlaxoSmithKline PLC over the sale of generic versions of GSK's Paxil by Apotex Inc., bringing the total damages awarded to Mylan to about $120.6 million....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.